Knox City’s Kinlee Eaton, a standout in community involvement as well as academics and athletics, was recently selected as the Black Plumbing/@ Abilene Teachers Federal Credit Union Star Student of ...
Merck has opened a new manufacturing plant in Durham, NC which will make HPV vaccines, including its quadrivalent vaccine Gardasil and nine-valent vaccine Gardasil 9 … ...
Merck has opened a $1 billion, 225,000-square-foot facility at its Durham campus dedicated to vaccine manufacturing, the drug giant announced Tuesday. Merck has opened a $1 billion, 225,000-square ...
(Reuters) -Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S. manufacturing in the face of President Donald Trump's ...
Opening highlights effort to expand U.S. manufacturing through a $1 billion investment DURHAM, N.C., March 11, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States ...
March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...
A lower dollar and safe-haven moves brought on by concerns about a global trade dispute caused gold prices to increase steadily on Monday, March 10th, in the domestic market, with the exception of ...
Today, Thursday, March 6, gold prices in major Indian cities like Hyderabad and Chennai fell precipitously as the rupee gained momentum. Following new tariff reprisals, in which China and Canada ...
Pharmaceutical giant Merck may build a $900 million manufacturing facility near Greenville. The state of Delaware has offered Merck a $30.2 million grant to encourage the company to choose the ...
Merck KGaA’s healthcare division reported 7% net sales growth in 2024. Image credit: Shutterstock/Below the Sky Merck KGaA reaffirmed its strong performance in the healthcare sector in its FY 2024 ...
A new patent dispute is brewing between Halozyme Therapeutics (NASDAQ:HALO), a biotech focused on drug delivery technology, and Merck (NYSE:MRK) over an injectable version of the New Jersey-based ...
A dispute over a microscopic enzyme is threatening Merck & Co. plans to sell a new version of Keytruda, the cancer drug that generates nearly half of the company’s sales. Merck has been tweaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback